ProPhase Labs, Inc. Option Indexed to Issuer's Equity, Strike Price (Deprecated 2014-01-31)
ProPhase Labs, Inc. (PRPH) reported Option Indexed to Issuer's Equity, Strike Price (Deprecated 2014-01-31) of 45 USD/shares_unit for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-14.
Discontinued › Notes › Equity
us-gaap:OptionIndexedToIssuersEquityStrikePrice · last filed 2012-11-14
- 2012-09-30: Option Indexed to Issuer's Equity, Strike Price (Deprecated 2014-01-31) 9 month 45.00 USD/shares_unit.
- 2012-06-30: Option Indexed to Issuer's Equity, Strike Price (Deprecated 2014-01-31) 6 month 45.00 USD/shares_unit.
| Period end | Option Indexed to Issuer's Equity, Strike Price (Deprecated 2014-01-31) 6 month | Option Indexed to Issuer's Equity, Strike Price (Deprecated 2014-01-31) 9 month |
|---|---|---|
| 2012-09-30 | 45.00 USD/shares_unit 10-Q · filed 2012-11-14 | |
| 2012-06-30 | 45.00 USD/shares_unit 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |